BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1376037)

  • 1. CD5-like phorbol-ester responsiveness in conventional B cells activated through surface immunoglobulin.
    Rothstein TL; Kolber DL; Cohen DP
    Ann N Y Acad Sci; 1992 May; 651():176-8. PubMed ID: 1376037
    [No Abstract]   [Full Text] [Related]  

  • 2. Phorbol ester activates CD5+ leukaemic B cells via a T cell-independent mechanism.
    Tangye SG; Weston KM; Raison RL
    Immunol Cell Biol; 1995 Feb; 73(1):44-51. PubMed ID: 7539402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin.
    Teutsch M; Higer M; Wang D; Wortis HW
    Int Immunol; 1995 Mar; 7(3):381-92. PubMed ID: 7540861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines and cross-linking of sIgM augment PMA-induced activation of human leukaemic CD5+ B cells.
    Tangye SG; Weston KM; Raison RL
    Immunol Cell Biol; 1997 Dec; 75(6):561-7. PubMed ID: 9492192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways.
    Cong YZ; Rabin E; Wortis HH
    Int Immunol; 1991 May; 3(5):467-76. PubMed ID: 1716972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of phorbol ester responsiveness in conventional B cells after activation via surface Ig.
    Rothstein TL; Kolber DL; Murphy TP; Cohen DP
    J Immunol; 1991 Dec; 147(11):3728-35. PubMed ID: 1719085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TPA (12-O-tetradecanoyl-phorbol-13-acetate) activation and differentiation of human peripheral B lymphocytes.
    Aman P; Gordon J; Klein G
    Immunology; 1984 Jan; 51(1):27-34. PubMed ID: 6606617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of CD23 is a consequence of B-cell activation. Implications for the analysis of B-cell lineages.
    Rabin E; Cong YZ; Wortis HH
    Ann N Y Acad Sci; 1992 May; 651():130-42. PubMed ID: 1376028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isotype switching in CD5 B cells.
    Whitmore AC; Haughton G; Arnold LW
    Ann N Y Acad Sci; 1992 May; 651():143-51. PubMed ID: 1376029
    [No Abstract]   [Full Text] [Related]  

  • 10. IL-10 production by CD5 B cells.
    O'Garra A; Howard M
    Ann N Y Acad Sci; 1992 May; 651():182-99. PubMed ID: 1376039
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4.
    Rigley KP; Callard RE
    Eur J Immunol; 1991 Mar; 21(3):535-40. PubMed ID: 1707000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes.
    Wortis HH; Teutsch M; Higer M; Zheng J; Parker DC
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3348-52. PubMed ID: 7536930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion.
    Karras JG; Morris DL; Matulka RA; Kramer CM; Holsapple MP
    Toxicol Appl Pharmacol; 1996 Apr; 137(2):275-84. PubMed ID: 8661353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
    Suzuki T; Butler JL; Cooper MD
    J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The leukocyte-common antigen (CD45) complex and B-lymphocyte activation.
    Zola H; Melo JV; Zowtyj HN; Nikoloutsopoulos A; Skinner J
    Hum Immunol; 1990 Apr; 27(4):368-77. PubMed ID: 2138599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phorbol myristate acetate inhibits anti-IgM-mediated signaling in resting B cells.
    Mizuguchi J; Beaven MA; Li JH; Paul WE
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4474-8. PubMed ID: 3086884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and function of DRC-1 antigen.
    Bosseloir AL; Antoine N; Heinen E; DeFrance T; Schuurman H; Simar L
    Adv Exp Med Biol; 1994; 355():243-8. PubMed ID: 7535974
    [No Abstract]   [Full Text] [Related]  

  • 18. Proliferation and differentiation of human CD5+ and CD5- B cell subsets activated through their antigen receptors or CD40 antigens.
    Defrance T; Vanbervliet B; Durand I; Briolay J; Banchereau J
    Eur J Immunol; 1992 Nov; 22(11):2831-9. PubMed ID: 1385152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Ig antibody inhibits the phorbol ester-induced stimulation of peritoneal B cells.
    Rothstein TL; Kolber DL
    J Immunol; 1988 Dec; 141(12):4089-93. PubMed ID: 3264301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ly-1 B-lineage cells downregulate the number and proliferation of B-cell precursors.
    Kruger MG; Riley R; Elia J
    Ann N Y Acad Sci; 1992 May; 651():170-2. PubMed ID: 1376035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.